Luomala M - Search Results

1

A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis.

Luomala M, Lehtimäki T, Elovaara I, Wang X, Ukkonen M, Mattila K, Laippala P, Koivula T, Hurme M. Luomala M, et al. J Neurol Sci. 2001 Apr 1;185(2):123-7. doi: 10.1016/s0022-510x(01)00482-8. J Neurol Sci. 2001. PMID: 11311293

2

Plasminogen activator inhibitor 1 gene and risk of MS in women.

Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimäki T. Luomala M, et al. Neurology. 2000 May 9;54(9):1862-4. doi: 10.1212/wnl.54.9.1862. Neurology. 2000. PMID: 10802801

3

Promoter polymorphism of IL-10 and severity of multiple sclerosis.

Luomala M, Lehtimäki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I. Luomala M, et al. Acta Neurol Scand. 2003 Dec;108(6):396-400. doi: 10.1034/j.1600-0404.2003.00165.x. Acta Neurol Scand. 2003. PMID: 14616291

4

Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.

Lehtimäki T, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Mattila K, Ilveskoski E, Luomala M, Saikku P, Knuuti J, Hurme M. Lehtimäki T, et al. Among authors: luomala m. Pharmacogenetics. 2003 Oct;13(10):633-9. doi: 10.1097/00008571-200310000-00007. Pharmacogenetics. 2003. PMID: 14515062 Clinical Trial.

5

Suppression of immune system genes by methylprednisolone in exacerbations of multiple sclerosis. Preliminary results.

Airla N, Luomala M, Elovaara I, Kettunen E, Knuutila S, Lehtimäki T. Airla N, et al. Among authors: luomala m. J Neurol. 2004 Oct;251(10):1215-9. doi: 10.1007/s00415-004-0516-y. J Neurol. 2004. PMID: 15503100

6

Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis.

Luomala M, Elovaara I, Koivula T, Lehtimäki T. Luomala M, et al. Ann Neurol. 1999 Apr;45(4):546-7. doi: 10.1002/1531-8249(199904)45:4<546::aid-ana22>3.0.co;2-v. Ann Neurol. 1999. PMID: 10211485 No abstract available.

7

Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.

Elovaara I, Ukkonen M, Leppäkynnäs M, Lehtimäki T, Luomala M, Peltola J, Dastidar P. Elovaara I, et al. Among authors: luomala m. Arch Neurol. 2000 Apr;57(4):546-51. doi: 10.1001/archneur.57.4.546. Arch Neurol. 2000. PMID: 10768630 Clinical Trial.

8

The combination of HLA-DR1 and HLA-DR53 protects against MS.

Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimäki T. Luomala M, et al. Neurology. 2001 Feb 13;56(3):383-5. doi: 10.1212/wnl.56.3.383. Neurology. 2001. PMID: 11171905

9

Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women.

Mattila KM, Luomala M, Lehtimäki T, Laippala P, Koivula T, Elovaara I. Mattila KM, et al. Among authors: luomala m. Neurology. 2001 May 8;56(9):1246-7. doi: 10.1212/wnl.56.9.1246. Neurology. 2001. PMID: 11342704 No abstract available.

10

Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.

Pulkkinen K, Luomala M, Kuusisto H, Lehtimäki T, Saarela M, Jalonen TO, Elovaara I. Pulkkinen K, et al. Among authors: luomala m. Acta Neurol Scand. 2004 May;109(5):342-7. doi: 10.1046/j.1600-0404.2003.00233.x. Acta Neurol Scand. 2004. PMID: 15080861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters